Delivery Order SPE2DR25D3017-SPE2DR26F3EZ4
Award Date 12/19/25
Potential Completion Date 12/22/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,976.49 by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract operates under firm fixed-price terms with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is executed as a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order on April 24, 2025, valued at $6,707.89 for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is set to be completed by April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was issued by the Medical Supply Chain division of the Defense Logistics Agency under the federal government's medical procurement...
- AmerisourceBergen Drug Corp was awarded a $2,361.39 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of NovoLog Penfill 100 Unit/ML 3ML insulin pens. This non-set-aside award is scheduled for completion by November 17, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,111.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,345.20 on December 15, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,204.12 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. Issued on August 27, 2025, this firm fixed price delivery order is scheduled for completion by August 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under a larger contract vehicle and reflects the...
- The Defense Logistics Agency awarded a $8,744.03 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a completion date of December 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing as a major...
- The Defense Logistics Agency awarded a $1,161.80 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a direct procurement under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract requires fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania, where the company maintains...